Stocks in Focus: CONSOL Energy Inc. (NYSE:CNX), American Airlines Group Inc. (NASDAQ:AAL), Chemtura Corporation (NYSE:CHMT), Theravance Biopharma (NASDAQ:TBPH), Vermilion Energy (NYSE:VET)


On Wednesday shares of CONSOL Energy Inc. (NYSE:CNX) closed at $30.87. Company’s sales growth for last 5 years was -5.10% and EPS growth for next 5 years is recorded as 10.30%. CONSOL Energy Inc. (NYSE:CNX is narrowing its oil and gas focus in Ohio to just two counties. Last quarter the Canonsburg, Pennsylvania-based company drilled mostly in just five counties in the Utica and Marcellus shale plays: two in Pennsylvania and one in West Virginia.

American Airlines Group Inc. (NASDAQ:AAL) in last trading activity moved down -4.51% to close at $48.88. Company weekly performance is -4.90% while its quarterly performance stands at -3.24%. American Airlines Group Inc. (NASDAQ:AAL) is -12.85% away from its 52 week high. Pilots at American Airlines Group Inc. (NASDAQ:AAL) are being told to delete and reload an app that provides navigational charts on their company-issued Apple Inc. iPads after a software glitch led to flight delays.

On last trading day Chemtura Corporation (NYSE:CHMT) moved down -0.59% to close at $30.12. Its volatility for the week is 1.83% while volatility for the month is 2.15%. CHMT’s sales growth for past 5 years was -1.00% and its EPS growth for past 5 years was 61.70%. Chemtura Corporation (NYSE:CHMT) monthly performance is 10.53%. Chemtura Corporation (NYSE:CHMT) reported Q1 EPS of $0.30, $0.13 better than the analyst estimate of $0.17. Revenue for the quarter came in at $438 million versus the consensus estimate of $475.68 million.

Theravance Biopharma, Inc. (NASDAQ:TBPH) has 5.10% insider ownership while its institutional ownership stands at 63.50%. In last trading activity company’s stock closed at $16.95. Theravance Biopharma, Inc. (NASDAQ:TBPH) announced that data from studies of VIBATIV® (telavancin), the Company’s FDA-approved antibiotic, presented at the 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) in Copenhagen, Denmark, on April 25 – 28, 2015.

On last trading day Vermilion Energy Inc. (NYSE:VET) moved down -0.04% to close at $47.95. Its volatility for the week is 1.72% while volatility for the month is 2.60%. Vermilion Energy Inc. (NYSE:VET) monthly performance is 14.03%.


Leave a Reply

Your email address will not be published. Required fields are marked *